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Nanoemulsions present a high potential to be used in food products due to their advantages over con-
ventional emulsions (e.g. higher stability to gravitational separation and droplet aggregation and
enhanced bioavailability of encapsulated compounds), however their application to foods is hindered by
some concerns about potential risks associated with their ingestion. The knowledge of the behaviour of
nanoemulsions as well as the fate of bioactive compounds encapsulated within them in the gastroin-
testinal (GI) tract is of utmost importance to assess their safety for human consumption and to produce
delivery systems that provide an optimized bioactivity of the encapsulated compound. In this work, a
dynamic gastrointestinal model, comprising the simulation of stomach, duodenum, jejunum and ileum,
was used to evaluate the behaviour of curcumin nanoemulsions stabilized by biopolymer emulsiﬁers
(lactoferrin and lactoferrin/alginate multilayer structure) under GI conditions. The interfacial charac-
teristics of curcumin nanoemulsions had a signiﬁcant impact on their physicochemical stability within
the simulated GI tract. Also, results suggested that alginate coating may be able to control the rate of lipid
digestion and free fatty acids adsorption within the GI tract, but the encapsulated lipid is digested at the
same extent, releasing the lipophilic bioactive compound. This work contributes to an improved un-
derstanding of how multilayer nanoemulsions behave within the GI tract and this knowledge will be
useful for the optimization of delivery systems that improve the physicochemical stability of emulsions
in food products, while still releasing encapsulated lipophilic bioactive compounds.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
The growing consumers' awareness of the link between food
and health and the consequent increase in demand for functional
foods are stimulating the innovation and the development of new
products in the food industry. Many health-promoting compounds
are lipophilic (e.g. curcumin, u-3 fatty acids, lycopene, phytos-
terols, quercetin, resveratrol), however their utilization by food
industry is limited due to their low bioavailability and difﬁculties
associated with their incorporation into food matrices
(McClements & Xiao, 2012). In particular, curcumin (a natural
polyphenolic phytochemical extracted from the powdered rhi-
zomes of turmeric spice) has been reported to have many bio-
logical activities, such as antitumor, anti-oxidant, anti-microbial
and anti-inﬂammatory properties. However, its application as aPinheiro).bioactive ingredient is currently limited by its poor water solubi-
lity (hindering its incorporation into many food products) and low
bioavailability (which means that its health-promotion effects may
not be effective) (Ahmed, Li, McClements, & Xiao, 2012).
Emulsion-based delivery systems are one of the vehicles that are
being increasingly used to both protect and deliver lipophilic
bioactive compounds (increasing their bioavailability) and to
achieve their incorporation into food products (Salminen,
Herrmann, & Weiss, 2013). These systems can be produced
entirely from bio-based materials, using simple processing oper-
ations such as blending or homogenization (Tokle & McClements,
2011). For example, lactoferrin, a globular protein derived from
milk with a wide range of reported biological activities (e.g. anti-
oxidant antimicrobial, cancer prevention, and modulation of im-
mune responses) can be used as natural emulsiﬁer to enhance the
formation and stabilization of oil-in-water emulsions (Balc~ao et al.,
2013; Shimoni, Shani Levi, Levi Tal, & Lesmes, 2013).
The design of emulsion-based delivery systems to control
digestion, release and absorption of encapsulated lipophilic
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challenges of food industry. Digestibility of lipids and release of
bioactive lipophilic compounds encapsulated within emulsion-
based delivery systems can be controlled by coating lipid drop-
lets with biopolymer coatings. These multilayer emulsions can be
formed by electrostatic deposition of ionic biopolymers onto
oppositely charged lipid droplets (layer-by-layer (LbL) technique)
(Decher & Schlenoff, 2003; Li et al., 2010). Alginate, a naturally
occurring anionic polysaccharide typically obtained from brown
seaweed, is one of the polyelectrolytes most used for LbL depo-
sition (Maurstad, Mørch, Bausch, & Stokke, 2008; Zhou et al.,
2010), which is probably due to its biocompatibility, low
toxicity and relatively low cost (Lee & Mooney, 2012). The design
of the multilayer coatings interface will depend on their speciﬁc
application: multilayer coatings can be used to increase the
bioavailability of incorporated bioactive compounds, being in this
case essential that it is broken down within the GI tract so that
the bioactive compounds can be released and absorbed. It can
also be designed to be completely indigestible within the GI tract,
when used to reduce the caloric content of foods by preventing
lipases from accessing encapsulated lipids (McClements, 2010).
There is a wide range of emulsion-based delivery systems that
can be assembled entirely from bio-based materials. Nano-
emulsions (radius <100 nm) present advantages over conven-
tional emulsions, such as higher stability to gravitational
separation and droplet aggregation, higher optical clarity and
enhanced bioavailability of encapsulated lipophilic bioactive
compounds (due to their small size) (McClements & Xiao, 2012).
Despite of the potential beneﬁts of nanoemulsions, their appli-
cation to foods is hindered by some concerns about potential risks
associated with the ingestion of nanostructures, such as the po-
tential toxicity of some components used to produce them (e.g.
surfactants and organic solvents) and their ability to alter the
biological fate of ingested materials and encapsulated bioactive
compounds, which could potentially have some adverse effects on
human health (McClements, 2013). The ﬁrst issue can be solved by
using only bio-based food grade materials when producing
nanoemulsions; the second issue is a broader one and must be
evaluated (ideally) in vivo, or at least in vitro. The knowledge of the
behaviour of nanoemulsions as well as the fate of bioactive
compounds encapsulated within them in the GI tract is of utmost
importance to either assess their safety for human consumption
and to produce tailored delivery systems (i.e. with optimized
bioactivity). In recent years, considerable efforts have been made
in understanding the physicochemical behaviour of nano-
emulsions within the GI tract (Ahmed et al., 2012; Salvia-Trujillo,
Qian, Martín-Belloso,&McClements, 2013), however further work
is clearly needed because there is still a lack of knowledge
regarding the major factors that inﬂuence the biological fate of
ingested nanoemulsions. Also, most of the works that evaluate the
behaviour of emulsions under gastrointestinal conditions use
static in vitro digestion models and simpliﬁed gastrointestinal
conditions that do not accurately simulate the complex physico-
chemical and physiological processes that occur within the hu-
man gastrointestinal tract (Li et al., 2010; Mun, Decker, &
McClements, 2007). Therefore, being very difﬁcult (often infea-
sible) the use of in vivo models (high costs and ethical constrains
often involved), there is a need of using more realistic in vitro
gastrointestinal models.
In this work, a dynamic digestion model comprising the simu-
lation of stomach, duodenum, jejunum and ileum, has been used to
evaluate the behaviour of curcumin nanoemulsions stabilized by
biopolymer emulsiﬁers (lactoferrin and lactoferrin/alginate multi-
layer structure) under gastrointestinal conditions.2. Materials and methods
2.1. Materials
Corn oil (Fula) was purchased from a local supermarket in Braga
(Portugal) and was used without further puriﬁcation. Curcumin
was purchased from SigmaeAldrich (St. Louis, MO), lactoferrin was
acquired from DMV International (Veghel, The Netherlands) and
sodium alginate was purchased from Kelco International, Ltd. (UK).
Pepsin from porcine gastric mucosa (600 U mL1), lipase from
porcine pancreas (40 U mL1), pancreatin from porcine pancreas
(8USP), bile extract porcine and the salts used for preparing the
gastric and small intestinal electrolyte solutions, hydrochloric acid
and sodium bicarbonate were purchased from SigmaeAldrich (St.
Louis, MO). Chloroform was obtained from Fisher Scientiﬁc (NJ,
USA), acetone from Fisher Chemical (UK) and sodium hydroxide
and phenolphthalein from Panreac (Spain).
2.2. Emulsion preparation
Curcumin nanoemulsions (stabilized by lactoferrin) were pre-
pared by homogenizing 5 wt.% corn oil containing 0.1 wt.% of cur-
cumin with 95 wt.% aqueous emulsiﬁer solution (lactoferrin at a
concentration of 2%), using an Ultra-Turrax homogenizer (T 25, Ika-
Werke, Germany) for 2 min followed by passage through a high
pressure homogenizer (NanoDeBee, Bee International, South
Easton, Massachusetts, USA) at 20,000 Psi (137.9 MPa), for
20 cycles.
Curcumin multilayer nanoemulsions (stabilized by lactoferrin/
alginate multilayer structure) were prepared by adding the curcu-
min nanoemulsion (pH 4, at which lactoferrin has the maximum
charge) dropwise with a syringe pump (NE-1000, New Era Pump
Systems, Inc., USA) to an alginate solution (pH 7, at which alginate
has the maximum charge) under stirring for 30 min. The multilayer
nanoemulsion was then treated with sonication (during 2 min at a
frequency of 50e60 kHz) (Brason 5510, Bransonic® ultrasonic
cleaner, USA) to disrupt any ﬂocculated droplets formed during its
preparation (Li et al., 2010). Different concentrations of alginate
were tested in order to optimize the formulation. The ﬁnal pH of
the multilayer nanoemulsions was around 5.
Both nanoemulsions were kept at 4 C in the dark before char-
acterization and in vitro digestion.
2.3. In vitro digestion
2.3.1. Gastrointestinal model
A dynamic gastrointestinal system was used in the in vitro
digestion experiments. This model simulates the main events that
occur during digestion and consists of four compartments simu-
lating the stomach, duodenum, jejunum and ileum. Each
compartment consists in two connected glass reactors with a
ﬂexible wall inside and water is pumped around the ﬂexible walls
to maintain the temperature at 37 C and to enable the simulation
of the peristaltic movements (by the alternate compression and
relaxation of the ﬂexible walls). The changes in water pressure are
achieved by peristaltic pumps which alter the ﬂow direction ac-
cording to the time controlling devices connected to them. The
compartments are connected by silicone tubes and, at a predeﬁned
time, a constant volume of chyme is transferred. All compartments
are equipped with pH electrodes and pH values are controlled by
the secretion of HCl (1 mol L1) into the stomach and
NaHCO3 (1 mol L1) into the intestinal compartments. The gastric
and intestinal secretions are added via syringe pumps at pre-set
ﬂow rates. The jejunum and ileum compartments are connected
with hollow-ﬁbre devices (SpectrumLabs Minikros®, M20S-100-
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and to modify electrolyte and bile salts concentration of the chyme
(Reis et al., 2008).
It should be noted that, although at the mouth stage there may
be changes in emulsions' size and interfacial characteristics, inﬂu-
encing the emulsions' fate in the GI tract (McClements et al., 2012),
this phase was not included once the sample is liquid (and there-
fore the mastication is not relevant and the residence time in the
mouth is very low) and the samples do not contain starch (i.e. the
primary enzyme present in saliva, amylase, would not act).
2.3.2. Experimental conditions
In vitro digestion was performed as described by other authors
(Reis et al., 2008) with some modiﬁcations. A volume of 60 mL of
curcumin nanoemulsions (both nanoemulsions and multilayer
nanoemulsions) was introduced into the dynamic gastrointestinal
system (gastric compartment) and the experiment was run for a
total of 5 h, simulating average physiological conditions of GI tract
by the continuous addition of gastric, duodenal, jejunal and ileal
secretions. The gastric secretion consisted of pepsin and lipase in a
gastric electrolyte solution (NaCl 4.8 g L1, KCl 2.2 g L1,
CaCl2 0.22 g L1 and NaHCO3 1.5 g L1), secreted at a ﬂow rate of
0.33 mL min1. The pH was controlled to follow a predetermined
curve (from 4.8 at t ¼ 0 to 1.7 at t ¼ 120 min) by secreting
HCl (1 mol L1).
The duodenal secretion consisted of a mixture of 4% (w/v)
porcine bile extract, 7% (w/v) pancreatin solution and small intes-
tinal electrolyte solution (SIES) (NaCl 5 g L1, KCl 0.6 g L1,
CaCl2 0.25 g L1) secreted at a ﬂow rate of 0.66 mL min1. The je-
junal secretion ﬂuid consisted of SIES containing 10% (v/v) porcine
bile extract solution at a ﬂow rate of 2.13 mL min1. The ileal
secretion ﬂuid consisted of SIES at a ﬂow rate of 2.0 mL min1. The
pH in the different parts of small intestine was controlled by the
addition of 1 mol L1 NaHCO3 solution to set-points of 6.5, 6.8 and
7.2 for simulated duodenum, jejunum and ileum, respectively.
During in vitro digestion, samples were collected directly from the
lumen of the different compartments, from the jejunal and ileal
ﬁltrates and from the ileal delivery. The jejunal and ileal ﬁltrates
were used to determine the bioaccessible fraction of curcumin. The
samples were analysed for size, z-potential and free fatty acids.
Both curcumin nanoemulsions were tested in the dynamic
gastrointestinal model at least in triplicate.
2.4. Particle size
The particle size of the emulsions was measured at different
stages of digestion by dynamic light scattering (Zetasizer Nano ZS,
Malvern Instruments, Worcestershire, UK). The Z-average mean
diameter was calculated by the instrument using Stokes-Einstein
equation, assuming that nanoemulsion droplets were spherical.
Before measurement, the samples were diluted at a ratio of
1:100 (v/v) in an appropriate buffer solution with the same pH as
the aqueous phase of the sample (KCleHCl, 10 mmol L1, pH 2) for
stomach sample and phosphate buffer (10 mmol L1, pH 7) for
initial and small intestine samples (Hur, Decker, & McClements,
2009) at room temperature to avoid multiple scattering effects.
The measurements were performed in triplicate.
2.5. z-potential
The z-potential values of nanoemulsions at different stages of
digestion were measured using a particle electrophoresis instru-
ment (Malvern Instruments, Worcestershire, UK). The z-potential
was determined by measuring the direction and velocity of droplet
movement in the applied electric ﬁeld and was calculated by theinstrument using the Smoluchowski model.
The samples were diluted at a ratio of 1:100 (v/v) in appropriate
buffer solution (KCleHCl, 10 mmol L1, pH 2) for stomach sample
and phosphate buffer (10 mmol L1, pH 7) for initial and small in-
testine samples (Hur et al., 2009) at room temperature before
measurement. Each individual z-potential measurement was
determined from the average of three readings.
2.6. Transmission electron microscopy (TEM)
TEM micrographs were conducted on a Zeiss EM 902 A micro-
scope (Germany) at accelerating voltages of 50 kV and 80 kV. The
samples were prepared by dropping nanoemulsion solutions onto
copper grids coated with carbon ﬁlm, followed by staining with
uranyl acetate and natural drying at room temperature.
2.7. Free fatty acids released
The digestion activity was measured by determining the
amount of free fatty acids (FFA) released from curcumin nano-
emulsions using a titration method (Pinsirodom, 2005). Brieﬂy,
5 mL of jejunal ﬁltrate, ileal ﬁltrate and ileal delivery samples were
collected and 10 mL of acetone were added to quench the enzymes'
activity and 3 drops of 1% (w/v) phenolphthalein were added as an
indicator. A direct titration with 0.1 mol L1 NaOH using a burette
was performed and the volume of NaOH added until the titration
end point was determined and used to calculate the concentration
of FFA produced by lipolysis. Therefore, the percentage of free fatty
acids released was calculated from the number of moles of NaOH
required to neutralize the FFA divided by the number of moles of
FFA that could be produced from triglycerides if they were all
digested (assuming 2 FFA produced per 1 triacylglycerol molecule)
(Li, Hu, Du, Xiao, & McClements, 2011):
% FFA ¼ 100 
 




where vNaOH is the volume of sodium hydroxide required to
neutralize the FFA generated (in mL), mNaOH is the molarity of the
sodium hydroxide used (in mol L1), wlipids is the total weight of
corn oil initially present and Mlipid is the molecular weight of the
corn oil (based on their average fatty acid composition the molec-
ular weight of corn oil was considered to be 800 g mol1).
Once the carboxylic groups of alginate presented in the multi-
layer nanoemulsions can act as a buffer, interfering with the FFA
quantiﬁcation, a blank assay was performed only with alginate.
2.8. Curcumin bioaccessibility
It was assumed that the fraction of the original curcumin that
ended up in the micelle phase was a measure of curcumin bio-
accessibility (Ahmed et al., 2012) and that the mixed micelles that
contained the bioavailable curcumin fraction were able to pass the
hollow-ﬁbre membranes (i.e. corresponds to jejunal ﬁltrate and ileal
ﬁltrate samples), while undigested emulsions were retained
(Minekus et al., 2005). Curcumin bioaccessibility was determined
based on the methodology described by other authors (Ahmed et al.,
2012). Brieﬂy, 5 mL of the sample (jejunal or ileal ﬁltrate) were
vortexed with 5 mL of chloroform, and then centrifuged (Sigma
4K15, Germany) at 1750 rpm, at room temperature, for 10 min. The
bottom chloroform layer was collected and the extraction procedure
was repeatedwith the top layer. The second bottom chloroform layer
was added to the previously set aside chloroform layer, mixed, and
analysed in a UVeVIS spectrophotometer (Jasco V560, USA) at
Fig. 1. Inﬂuence of alginate concentration on the z-potential (a) and size (b) of multilayer nanoemulsions.
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determined from a previously prepared calibration curve of absor-
bance versus curcumin concentration in chloroform.2.9. Statistical analyses
All experiments were carried out at least in triplicate using
freshly prepared samples. The results were then reported as aver-
ages and standard deviations of these measurements. The statisti-
cal analyses were carried out using analysis of variance, Tukey
mean comparison test (p < 0.05) and linear regression analysis
(SigmaStat, trial version, 2003, USA).3. Results and discussion
3.1. Optimization of the multilayer nanoemulsion formulation
The optimum lactoferrin concentration required to form the
curcumin nanoemulsion composed of 5 wt% corn oil was deter-
mined (results not shown). A concentration of 2% was found to be
the minimum amount of lactoferrin required to form stable nano-
emulsions and, therefore, this concentration was used to prepare
the nanoemulsions.
Regarding multilayer nanoemulsions, the biopolymer concen-
tration used for their preparation must be carefully controlled to
avoid particle aggregation (due to charge neutralization, bridging
or depletion effects) (McClements, 2005). In order to establish the
optimum alginate concentration required to prepare stable multi-
layer nanoemulsions, different alginate concentrations (from 0 to
0.3 wt%) were tested and their effects on z-potential and particle
size were measured (Fig. 1).Fig. 2. Mean particle diameter of curcumin nanoemulsions stabilized by lactoferrin ( )
and lactoferrin/alginate ( ) as they pass through the dynamic in vitro digestion model.In the absence of alginate, lactoferrin-stabilized nanoemulsions
exhibited a z-potential of 27.47 ± 1.11 (at pH 4). As the concentra-
tion of alginate increased, the z-potential of the multilayer nano-
emulsions became increasingly negative until it reached a constant
value (z30 mV), at an alginate concentration of 0.20% (Fig. 1a).
This suggests that the anionic alginate molecules adsorbed to the
surfaces of lactoferrin-stabilized nanoemulsions until they became
saturated with alginate.
The increase in alginate concentration also inﬂuenced the par-
ticles' size (Fig. 1b). In the absence of alginate, lactoferrin-stabilized
nanoemulsions exhibited a diameter of 149.3 ± 4.9 nm. At low
alginate concentrations (<0.06%), a signiﬁcant increase in particle
size occurred, suggesting extensive droplet aggregation which can
be attributed to the low net charge on droplets as well as to
bridging ﬂocculation effects that occurred when droplet surfaces
were not saturated with alginate (Li et al., 2010). At alginate con-
centrations higher than 0.08%, an appreciable decrease in particles
size was observed, suggesting that the emulsions were not sus-
ceptible to droplet aggregation at these alginate concentrations.
This behaviour can be due to the strong electrostatic repulsion
between the droplets and to the saturation of the droplets surfaces
with alginate so that there was less bridging ﬂocculation
(Thanasukarn, Pongsawatmanit, & McClements, 2006).
Therefore, 0.2% (representing a proportion of 10:1 of lactoferrin/
alginate) was the alginate concentration selected for the prepara-
tion of multilayer nanoemulsions, since, at this concentration,
lactoferrin-stabilized nanoemulsions are completely coated by an
alginate layer and there is no signiﬁcant alginate excess in solution.
3.2. In vitro digestion
In vitro digestions were conducted in order to assess if the
presence of a dietary fibre (in this case alginate) coating around
lactoferrin-stabilized curcumin nanoemulsions inﬂuences their
behaviour within a simulated GI tract.
3.2.1. Inﬂuence of alginate on particle characteristics during in vitro
digestion
The effect of the alginate coating addition on particle size during
in vitro digestion can be seen in Fig. 2. At stomach stage, the mean
particle diameter of the nanoemulsions (stabilized by lactoferrin)
remained relatively small, although some coalescence phenomena
occurred (Fig. 3). On the contrary, the multilayer nanoemulsions
(stabilized by lactoferrin and alginate) were highly unstable under
gastric conditions, exhibiting a large increase in the particle size
(indicating that extensive droplet aggregation occurred) and a high
evidence of creaming (results not shown). This different behaviour
is related to differences in their interfacial characteristics. At acidic
Fig. 3. TEM images of curcumin nanoemulsions stabilized by lactoferrin and lactoferrin/alginate as they pass through the dynamic in vitro digestion model. The scale bar for all TEM
images is 0.5 mm.
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charged (Fig. 4) and consequently there is a strong electrostatic
repulsion between them, avoiding the emulsions' aggregation,
coalescence and ﬂocculation. On the other hand, alginate molecules
have a linear anionic chain with no side chains, and therefore they
are more susceptible to droplet aggregation through charge
neutralization and bridging effects since there is little steric
repulsion contribution (Tokle, Lesmes, Decker, & McClements,2012). Also, at acidic pH values, electrostatic attraction between
alginate and the cationic lactoferrin-stabilized nanoemulsions is
weakened because of the partial loss of negative charge on alginate
below its pKa values. This could have led to bridging ﬂocculation
(i.e. a single alginate molecule may have been partially detached
from one lipid droplet surface and became attached to another lipid
droplet) (Tokle, Lesmes, &McClements, 2010). Droplet aggregation
of lactoferrin/alginate-stabilized nanoemulsions at the stomach
Fig. 4. z-potential values of curcumin nanoemulsions stabilized by lactoferrin ( ) and
lactoferrin/alginate ( ) as they pass through the dynamic in vitro digestion model.
Fig. 5. Percentage of free fatty acids (FFA) released from lactoferrin (LF) and lacto-
ferrin/alginate (LF þ Al) stabilized nanoemulsions as they pass through the dynamic
in vitro digestion model: Initial ( ); Jejunal ﬁltrate ( ); Ileal ﬁltrate ( ) and Ileal
delivery ( ).
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Under intestinal conditions, both nanoemulsions andmultilayer
nanoemulsions exhibited high particle diameters due to particle
aggregation (ﬂocculation and coalescence of emulsions) (Figs. 2 and
3). At these stages of digestion, bile salts may have been able to
displace some lactoferrin from the lipid surface and lipase mole-
cules were probably able to access and hydrolyse the lipids, pro-
ducing free fatty acids (FFA), monoacylglycerides (MAG) and
diacylgycerides (DAG) at the droplet surfaces. These surface-active
products of digestion are ineffective at stabilizing oil-in-water
emulsions against coalescence (Mun et al., 2007), which can
explain the observed emulsions instability (i.e. high particle sizes).
As expected, jejunal and ileal ﬁltrates (i.e. the fraction absorbed
at jejunum and ileum compartments, respectively) exhibit particle
sizes signiﬁcantly (p < 0.05) lower than the ileal delivery (i.e.
fraction that is not absorbed in the small intestine).
It should be noted that dynamic light scattering has a size lim-
itation: it is only suitable for themeasurement of particle diameters
up to fewmicrons, therefore, the results obtained for some samples
should be analysed with care.
Regarding the effect of digestion on droplet charge (Fig. 4), it
was observed that at stomach stage, the electrical charge of both
emulsions became more positive which can be attributed to
changes in solutions conditions (pH and ionic strength), competi-
tive displacement of the original emulsiﬁer by surface active ma-
terials present in the gastric electrolyte solution, or adsorption of
charged species from gastric electrolyte solution on top of the
original emulsiﬁer coating (Hur et al., 2009). In fact, regarding the
multilayer nanoemulsion, the external alginate layer should be
protonated at pHz 2, not conferring charge to the nanoemulsions
and thus can be more easily desorbed. In this way, the positive
charge of lactoferrin can contribute to a higher positive z-potential
of multilayer nanoemulsions.
Once the gastric electrolyte solution contains pepsin, this pro-
tease may have hydrolysed the adsorbed lactoferrin molecules,
thus facilitating their competitive displacement. Although, even if
hydrolysis has occurred, the positively charged peptide should not
have been displaced in a high extension, once at pHz 2, the amine
groups are all protonated, on the contrary of the initial solution,
with higher pH.
Comparatively with nanoemulsions stabilized only by lacto-
ferrin, multilayer nanoemulsions exhibit a lower positive charge
under gastric conditions, which suggests that, despite the fact that,
at acid pH, the electrostatic attraction between alginate and lac-
toferrin is weakened, alginate remained partly bound to
lactoferrin-coated lipid droplets, thus protecting lactoferrin.
At duodenal conditions (pH ¼ 6.5) both lactoferrin and
lactoferrin/alginate-stabilized nanoemulsions became highlynegatively charged. If there were no changes in the interfacial
composition, the lactoferrin-stabilized nanoemulsions would be
slightly positively charged at neutral pH, once the isoelectric point
(pI) of lactoferrin is between 8.4 and 9.0 (Farnaud & Evans, 2003).
Therefore, the fact that the nanoemulsion has high negative charge
suggests that there was a displacement of the lactoferrin layer from
lipid surfaces by surface-active anionic molecules (e.g. free fatty
acids, bile salts or lipase), the adsorption of anionic species (e.g. free
fatty acids, bile salts or lipase) on top of the lactoferrin layer, or
adsorption of small negatively charged ions from the small intes-
tinal electrolyte solution (Tokle et al., 2012). There are no signiﬁcant
differences (p > 0.05) between z-potential values of nanoemulsions
and multilayer nanoemulsions at the subsequent stages of diges-
tion process.3.2.2. Inﬂuence of alginate on lipid digestion
The effect of alginate coating on free fatty acids release was also
examined at the different stages of small intestine digestion (Fig. 5).
The overall extent of lipid digestion was fairly similar for both
nanoemulsions andmultilayer nanoemulsions, which suggests that
alginate coating did not prevent lipid digestion. However, there are
some differences in the percentage of FFA released in the different
stages and fractions of small intestine digestion.
The major difference was observed in the jejunal ﬁltrate frac-
tion, with lactoferrin/alginate-stabilized nanoemulsions having a
signiﬁcantly (p < 0.05) lower amount of FFA as compared to
lactoferrin-stabilized nanoemulsions. These results suggest that
lactoferrin/alginate stabilized-nanoemulsions were digested at a
slower rate than lactoferrin-stabilized nanoemulsions, which is in
agreement with previous works (Tokle et al., 2012). Alginate is
resistant to digestion in the stomach and small-intestine and has
the ability to strongly bind calcium ions, preventing them from
precipitating free fatty acids produced at the oil droplet surface (Hu,
Li, Decker, & McClements, 2010). The decrease in the rate of lipid
digestion in the presence of relatively small amounts of alginate has
been thus mainly attributed to its ability to bind calcium ions.
However, other physicochemical mechanisms may have occurred,
e.g. presence of coating around the lipid droplets that prevented
lipase from reaching their surface and binding multivalent cations
required for lipase activity (Hu et al., 2010).
Another interesting result is that the total percentage of FFA
absorbed in the small intestine (jejunum and ileum) is higher
(although not signiﬁcantly, p > 0.05) for lactoferrin-stabilized
nanoemulsions comparing to lactoferrin/alginate-stabilized
Fig. 6. Total bioaccessibility of curcumin during gastrointestinal transit of curcumin nanoemulsions stabilized by lactoferrin (a) and lactoferrin/alginate (b) in the dynamic in vitro
digestion model. Total bioaccessibility of curcumin is shown in the ﬁltrate samples of jejunal ( ) and ileal ( ) compartments at 1 h intervals and expressed as % related to curcumin
intake. The results are presented as the mean values of triplicate experiments.
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gests that absorption of calories in the small-intestine may be
reduced by addition of the alginate coating. This means that,
although FFA were released almost in the same extent for both
nanoemulsions and multilayer nanoemulsions (96 ± 7 and 92 ± 12,
respectively), the presence of alginate hindered FFA absorption.
These results suggest that alginate coating may be useful to
control the rate of lipid digestion and FFA adsorption within the
gastrointestinal tract, but it does not prevent the adsorption of
lipase to the lipid droplet and their consequent digestion. If the
objective of the multilayer system is to increase the bioaccessibility
of a water-insoluble bioactive compound (such as curcumin), it is
necessary for the carrier oil surrounding them to be digested ﬁrst,
releasing the bioactive compounds so they can be taken up by
mixed micelles (Tso, 2000).
3.2.3. Inﬂuence of alginate on curcumin bioaccessibility
Fig. 6 shows curcumin bioaccessibility, measured as curcumin
concentration in the mixed micelle phase, in the ﬁltrate samples of
jejunal and ileal compartments as a function of time for nano-
emulsions and multilayer nanoemulsions.
Curcumin bioaccessibility tends to increase with digestion time,
and this behaviour can be attributed to the formation of digestion
products that have the ability to form mixed micelles capable of
solubilizing highly lipophilic components such as curcumin.
For both lactoferrin and lactoferrin/alginate-stabilized nano-
emulsions the relative amount of curcumin was higher in the
ﬁltrate sample of jejunal compartment compared to the ileal
compartment, however lactoferrin/alginate-stabilized nano-
emulsions present a signiﬁcantly (p < 0.05) higher curcumin bio-
accessibility in ileal ﬁltrate at all times. This result is in agreement
with FFA release results (Fig. 5), i.e. for multilayer nanoemulsions
the higher curcumin bioaccessibility observed in ileal ﬁltrate was
related with the higher amount of FFA found in this fraction. The
access of lipases to encapsulated lipids is a critical step in deter-
mining the bioactivity of bioactive compounds, once the digestion
products from TAG digestion (DG, MG, and FFA) may themselves
become part of the mixed micelles, thereby increasing the overall
solubilizing capacity of the small intestine, increasing the bio-
accessibility and therefore the bioavailability of encapsulated
bioactive compounds (Porter, Trevaskis, & Charman, 2007). How-
ever, for both nanoemulsions, the total curcumin bioaccessibility is
relatively low with most of the curcumin being recovered in the
ileal deliveries and residues found adhered to the dynamic diges-
tion model walls after the digestion was completed. These low
values of curcumin bioaccessibility are quite surprising since pre-
vious works have reported higher curcumin bioaccessibility in oil-in-water emulsions stabilized also by proteins (Ahmed et al., 2012)
or by surfactants (Pinheiro et al., 2013). A possible reason for this
ﬁnding is that curcumin bound to lactoferrinmolecules or digestion
products of lactoferrin and therefore is not detected in the micelle
phase. Similar results were obtained by other authors, for emul-
sions nanolaminated with lactoferrin and b-lactoglobulin coatings
(Tokle, Mao, & McClements, 2013). In this work, it has been sug-
gested that lactoferrin is the responsible for the low b-carotene
bioavailability of in a simulated GIT.
4. Conclusions
A dynamic digestion model comprising stomach, duodenum,
jejunum and ileum was used to evaluate the impact of alginate
coating on the digestion of curcumin nanoemulsions stabilized by
lactoferrin. The interfacial characteristics of curcumin nano-
emulsions had a signiﬁcant impact on their physicochemical sta-
bility within the simulated GI tract: lactoferrin-stabilized
nanoemulsions were stable in the stomach but aggregated in the
small intestine, while lactoferrin/alginate-stabilized nano-
emulsions were unstable under both gastric and small intestinal
conditions. The overall extent of lipid digestion was fairly similar
for both nanoemulsions and multilayer nanoemulsions, which
suggests that alginate coating did not prevent lipid digestion.
However, for lactoferrin-stabilized nanoemulsions the highest
fraction of FFA was obtained in the jejunal ﬁltrate whereas for
lactoferrin/alginate-stabilized nanoemulsions the higher fraction of
FFA was found in the ileal ﬁltrate. Also, the higher curcumin bio-
accessibility observed in the ileal ﬁltrate of lactoferrin/alginate-
stabilized nanoemulsions is related with the higher amount of
FFA found in this fraction. These results suggest that alginate
coating may be instrumental in the control of the rate of lipid
digestion and FFA adsorption within the GI tract, but the encap-
sulated lipid is digested at the same extent, releasing the lipophilic
bioactive compound, which is then taken up by mixed micelles.
This work contributed to an improved understanding of how
multilayer nanoemulsions behave within the human GI tract and
this knowledge will be useful for the optimization of delivery sys-
tems that improve the physicochemical stability of emulsions in
food products, while still releasing encapsulated lipophilic com-
ponents in the GI tract.
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